- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02797509
Preventing Chronic Depression and PTSD in Stroke Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Family Caregivers
August 15, 2018 updated by: Ana-Maria Vranceanu, PhD, Massachusetts General Hospital
Preventing Chronic Depression and PTSD in Patients With Stroke Admitted to the Neuroscience ICU and Their Family Caregivers
The current study has the following objectives:
- To determine additional stroke patient (SP) and stroke caregiver (SC) factors including their perceptions of the stroke experience, hospitalization, and how they cope with its challenges; identify additional appropriate points to intervene (maladaptive coping styles, unrealistic expectations, inappropriate prioritization, misinformation about illness, and self care), and assess SP and SC preferences for the structure, mode of delivery (including potential for phone, video or a combination of these) and timing of an intervention.
- To develop, [using the preliminary data and information from aim 1], and test the feasibility and acceptability (primary outcomes) of a skills-based intervention for preventing chronic depression, anxiety, PTSD and decreased QoL in dyads at risk.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Eligible dyads (stroke patients and stroke caregivers) must meet the following inclusion criteria:
- Age 18 or older
- English fluency and literacy
- Hospitalized with an acute stroke (hemorrhagic and ischemic) within the past 2 weeks (patient) OR primary stroke caregiver of a stroke patient currently admitted with an acute stroke
- Stroke patient or stroke caregiver screens in for depression and/or PTSD
One or more of the following exclusion criteria will render a stroke patient (only) ineligible:
- Stroke patients who cannot participate due to the severity of stroke, cognitive impairment and/or aphasia, and are anticipated to not be able to participate due to permanent impairment as judged by the medical team.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Psychosocial Skills-Based Intervention
Based on information from Phase I (semi-structured interviews), the investigators will develop a detailed psychosocial intervention manual.
The intervention will be tailored consistent with American Heart Association (AHA) recommendations for stroke skills based interventions and will include 2 general and 4 specific modules (selected from 7 available).
Generally, in the intervention, stroke patients and stroke caregivers will learn skills to cope and manage stroke-related stressors.
It is anticipated that the intervention will have 6 sessions with 2 general sessions delivered within the NICU face to face and 4 tailored specific sessions to be delivered via live video using Vidyo.
Participants in the intervention group will also receive treatment as usual.
|
Subjects will attend group skills-based sessions once weekly (either in-person or via Vidyo) for 6 weeks and learn skills to cope and manage stroke-related stressors.
|
No Intervention: Minimally Enhanced Usual Care (MEUC)
Those in the MEUC will continue with their current care.
This may include meeting with nurses, physical therapist, medical doctors, and other members of the stroke patient's medical team.
Treatment as usual may also involve administration of Selective Serotonin Reuptake Inhibitors (SSRIs) to those patients with motor problems.
They will also received a pamphlet with educational information on stroke and recovery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of the Intervention
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Demonstration of feasibility will be assessed by the number of individuals who drop out of the study prior to completing the post- intervention assessment and the rate of missed sessions.
If drop-out rate or missed-session rate exceeds 25%, revisions to the intervention may be needed.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Change between post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures how satisfied the participant is with the intervention.
|
Change between post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure of Current Status (MOCS-A)
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures participants' current self-perceived status on several skills that are targeted by the intervention: the ability to relax at will, recognize stress-inducing situations, restructure maladaptive thoughts, be assertive about needs, and choose appropriate coping responses as needed.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Cognitive and Affective Mindfulness Scale (CAMS)
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures the degree to which individuals experience their thoughts and feelings.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
World Health Organization QOL Questionnaire (WHOQOL-BREF)
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures one's perceptions in the context of their culture and value systems, and their personal goals, standards and concerns.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Modified Rankin Scale (mRS)
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures the patient's prior stroke status and stroke severity.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures symptoms of anxiety and depression.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Posttraumatic Stress (PCL-S)
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures symptoms of posttraumatic stress disorder
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Current psychotropic meds and comorbid medical conditions,
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Study staff will collect information on patient's medical history and current medications to measure their mental health throughout the study.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Barthel Index
Time Frame: Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Measures the patient's prior stroke status and stroke severity.
|
Change between Baseline (week 0), post-intervention (week 8), 3-month Follow Up (week 13), and 6-month Follow Up (week 26)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age, Gender, Race, Ethnicity, Marital Status, Education Status, and Employment Status of Patients/Caregivers in the ICU
Time Frame: Baseline (week 0)
|
This questionnaire asks ICU patients/caregivers to report their age, gender, race, ethnicity, marital status, highest level of education, and primary employment status over the last 12 months.
|
Baseline (week 0)
|
Credibility Questionnaire
Time Frame: Baseline (week 0)
|
Measures how much the participant believes the intervention will work.
|
Baseline (week 0)
|
Prior Mental Health Questionnaire
Time Frame: Baseline (week 0)
|
This questionnaire asks ICU patients/caregivers to report any previous or current mental health conditions that they have been diagnosed with in the past.
|
Baseline (week 0)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
June 1, 2018
Study Completion (Actual)
August 1, 2018
Study Registration Dates
First Submitted
June 2, 2016
First Submitted That Met QC Criteria
June 7, 2016
First Posted (Estimate)
June 13, 2016
Study Record Updates
Last Update Posted (Actual)
August 17, 2018
Last Update Submitted That Met QC Criteria
August 15, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016P001190
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disorder
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Pôle Saint HélierINSA RennesCompleted
-
Pôle Saint HélierINSA RennesCompletedNeurological DisorderFrance
-
Collegium Medicum w BydgoszczyCompletedNeurological Complication of Procedure (Disorder)Poland
-
National Institute of Neurological Disorders and...CompletedNeurological DisorderUnited States
-
Forest Hills LabLiberyxCompletedNeurological DisorderUnited States
-
Riphah International UniversityRecruitingNeurological DisorderPakistan
-
University Hospital, ToulouseCompleted
-
Massachusetts General HospitalCompletedIntensive Care Neurological DisorderUnited States
-
South West London and St George's Mental Health...Active, not recruitingFunctional Neurological Symptom DisorderUnited Kingdom
Clinical Trials on Psychosocial Skills-Based Intervention
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMalignant Neoplasm | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
East Carolina UniversityNational Cancer Institute (NCI)CompletedDepression | Prostate Cancer | Cancer Survivor | Psychosocial Effects of Cancer and Its Treatment | Gastrointestinal Complications | Male Erectile Disorder | Urinary ComplicationsUnited States
-
Bozok UniversityEge UniversityCompletedPost Traumatic Stress Disorder | Violence | Violence, Sexual | Violence, Physical | Violence, Gender-Based | Post Traumatic Growth, PsychologicalTurkey
-
Centre hospitalier de l'Université de Montréal...Ministere de la Sante et des Services SociauxCompletedMarijuana Use | Young Adult | Psychotic DisorderCanada
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)Completed
-
Tokat Gaziosmanpasa UniversityCompletedStigmatization | Functionality | Peer Support | Chronic Mental Disorders | Psychosocial Skills Training | InsightTurkey
-
Queen's University, BelfastHarvard School of Public Health (HSPH); Discover the JourneyCompleted
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)Completed
-
Helse Stavanger HFThe Dam Foundation; Nasjonalforeningen for folkehelsenActive, not recruitingDementia | Alzheimer Disease | Vascular Dementia
-
Massachusetts General HospitalRecruitingEmotional Distress | Acute Neurological InjuryUnited States